Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Preferred Shares (2016 - 2025)

CorMedix's Preferred Shares history spans 12 years, with the latest figure at $92.0 for Q3 2025.

  • For Q3 2025, Preferred Shares fell 49.45% year-over-year to $92.0; the TTM value through Sep 2025 reached $92.0, down 49.45%, while the annual FY2024 figure was $137.0, N/A changed from the prior year.
  • Preferred Shares for Q3 2025 was $92.0 at CorMedix, roughly flat from $92.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $182.0 in Q1 2021 and bottomed at $92.0 in Q1 2025.
  • The 5-year median for Preferred Shares is $182.0 (2021), against an average of $164.5.
  • The largest annual shift saw Preferred Shares changed 0.0% in 2022 before it plummeted 49.45% in 2025.
  • A 5-year view of Preferred Shares shows it stood at $182.0 in 2021, then changed by 0.0% to $182.0 in 2022, then changed by 0.0% to $182.0 in 2023, then fell by 24.73% to $137.0 in 2024, then crashed by 32.85% to $92.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Preferred Shares are $92.0 (Q3 2025), $92.0 (Q2 2025), and $92.0 (Q1 2025).